126 related articles for article (PubMed ID: 2329449)
1. Microencapsulation using poly(DL-lactic acid). II: Effect of polymer molecular weight on the microcapsule properties.
Jalil R; Nixon JR
J Microencapsul; 1990; 7(2):245-54. PubMed ID: 2329449
[TBL] [Abstract][Full Text] [Related]
2. Microencapsulation using poly (L-lactic acid) III: Effect of polymer molecular weight on the microcapsule properties.
Jalil R; Nixon JR
J Microencapsul; 1990; 7(1):41-52. PubMed ID: 2308053
[TBL] [Abstract][Full Text] [Related]
3. Microencapsulation using poly(DL-lactic acid). I: Effect of preparative variables on the microcapsule characteristics and release kinetics.
Jalil R; Nixon JR
J Microencapsul; 1990; 7(2):229-44. PubMed ID: 2329448
[TBL] [Abstract][Full Text] [Related]
4. Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone.
Jalil R; Nixon JR
J Microencapsul; 1990; 7(1):53-66. PubMed ID: 2308054
[TBL] [Abstract][Full Text] [Related]
5. Microencapsulation using poly (L-lactic acid) II: Preparative variables affecting microcapsule properties.
Jalil R; Nixon JR
J Microencapsul; 1990; 7(1):25-39. PubMed ID: 2308052
[TBL] [Abstract][Full Text] [Related]
6. Microencapsulation using poly(L-lactic acid). I: Microcapsule properties affected by the preparative technique.
Jalil R; Nixon JR
J Microencapsul; 1989; 6(4):473-84. PubMed ID: 2585239
[TBL] [Abstract][Full Text] [Related]
7. Microencapsulation using poly(DL-lactic acid). III: Effect of polymer molecular weight on the release kinetics.
Jalil R; Nixon JR
J Microencapsul; 1990; 7(3):357-74. PubMed ID: 2384838
[TBL] [Abstract][Full Text] [Related]
8. Microencapsulation using poly(DL-lactic acid). IV: Effect of storage on the microcapsule characteristics.
Jalil R; Nixon JR
J Microencapsul; 1990; 7(3):375-83. PubMed ID: 2384839
[TBL] [Abstract][Full Text] [Related]
9. A method for the preparation of polylactic acid microcapsules of controlled particle size and drug loading.
Leelarasamee N; Howard SA; Malanga CJ; Ma JK
J Microencapsul; 1988; 5(2):147-57. PubMed ID: 3199303
[TBL] [Abstract][Full Text] [Related]
10. Simplex lattice design for the optimization of the microencapsulation of a water soluble drug using poly(lactic acid) and poly(lactide co-glycolide) copolymer.
Elkheshen S
J Microencapsul; 1996; 13(4):447-62. PubMed ID: 8808781
[TBL] [Abstract][Full Text] [Related]
11. Formulation factors affecting drug release from poly(lactic acid) (PLA) microcapsule tablets.
Kader A; Jalil R
Drug Dev Ind Pharm; 1999 Feb; 25(2):141-51. PubMed ID: 10065347
[TBL] [Abstract][Full Text] [Related]
12. Microenvironment-controlled encapsulation (MiCE) process: effects of PLGA concentration, flow rate, and collection method on microcapsule size and morphology.
Snider C; Lee SY; Yeo Y; Grégori GJ; Robinson JP; Park K
Pharm Res; 2008 Jan; 25(1):5-15. PubMed ID: 17914663
[TBL] [Abstract][Full Text] [Related]
13. Polymeric microspheres prepared by spraying into compressed carbon dioxide.
Bodmeier R; Wang H; Dixon DJ; Mawson S; Johnston KP
Pharm Res; 1995 Aug; 12(8):1211-7. PubMed ID: 7494836
[TBL] [Abstract][Full Text] [Related]
14. Controlled release of vancomycin from biodegradable microcapsules.
Ozalp Y; Ozdemir N; Kocagöz S; Hasirci V
J Microencapsul; 2001; 18(1):89-110. PubMed ID: 11201344
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties.
Jalil R; Nixon JR
J Microencapsul; 1990; 7(3):297-325. PubMed ID: 2200861
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
Lalla JK; Sapna K
J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
[TBL] [Abstract][Full Text] [Related]
17. The influence of polymer glass transition temperature and molecular weight on drug release from tablets containing poly(DL-lactic acid).
Omelczuk MO; McGinity JW
Pharm Res; 1992 Jan; 9(1):26-32. PubMed ID: 1589405
[TBL] [Abstract][Full Text] [Related]
18. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
19. Production of water-containing polymer microcapsules by the complex emulsion/solvent evaporation technique. Effect of process variables on the microcapsule size distribution.
Kentepozidou A; Kiparissides C
J Microencapsul; 1995; 12(6):627-38. PubMed ID: 8558385
[TBL] [Abstract][Full Text] [Related]
20. Poly(lactic acid) microencapsulated oxytetracycline: in vitro and in vivo evaluation.
Vidmar V; Smolcić-Bubalo A; Jalsenjak I
J Microencapsul; 1984; 1(2):131-6. PubMed ID: 6336522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
